Login / Signup
Christina A Raker
(Christina Raker)
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 4
Top Topics
Adverse Drug
Tyrosine Kinase
Free Survival
Diffusion Weighted Imaging
Top Venues
British journal of haematology
Urologia
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Charles J Milrod
,
Kang Woo Kim
,
Christina A Raker
,
Thomas A Ollila
,
Adam J Olszewski
,
Ari Pelcovits
Progression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysis.
British journal of haematology
(2024)
Charles J Milrod
,
Kang Woo Kim
,
Christina A Raker
,
Thomas A Ollila
,
Adam J Olszewski
,
Ari Pelcovits
Progression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysis.
British journal of haematology
204 (6) (2024)
Charles J Milrod
,
Kang Woo Kim
,
Christina A Raker
,
Thomas A Ollila
,
Adam J Olszewski
,
Ari Pelcovits
Progression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysis.
British journal of haematology
204 (6) (2024)
Abhishek A Sripad
,
Christina A Raker
,
Vivian W Sung
Overactive bladder medication: Anticholinergics versus mirabegron by specialty.
Urologia
89 (4) (2022)